AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Atenolol in Zambia
6 products registered with ZAMRA β 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ateleb 50mg tablets Tablet Uncoated | 149/013 | M/s. Leben Laboratories Pvt. Ltd | active | 14 Aug 2030 |
| Atenolol Denk 50 Film-coated Tablets | 130/021 | Denk Pharma GmbH & Co. KG | active | 1 Jul 2030 |
| Hipres-50 tablets Film Coated Tablets | 099/051 | Cipla Ltd | active | 18 Dec 2029 |
| Antipress 100 tablets Tablet Uncoated | 249/013 | Saga Lifesciences Limited | active | 20 Nov 2029 |
| Antipress 50 tablets Tablet Uncoated | 249/014 | Saga Lifesciences Limited | active | 20 Nov 2029 |
| Tenomac-50 tablet Film Coated Tablets | 192/020 | Macleods Pharmaceuticals Limited | active | 28 May 2029 |
Atenolol β ZAMRA Registration Details
ZAMRA (Zambia) has 6 registered products containing Atenolol, of which 6 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Atenolol registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.